Live tape
Top 8, mentions 7d7,519SPCX1,456 mentions▲ +0.09GOOGL1,389 mentions▲ +0.05NVDA1,219 mentions▲ +0.09MSFT869 mentions▲ +0.04QQQ711 mentions▲ +0.07META662 mentions▲ +0.04SPY609 mentions▲ +0.06AMZN604 mentions▲ +0.07

Equity · Healthcare

OMCL

NASDAQ

Omnicell, Inc.

$45.86 −1.62% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for OMCL to draw a line in its place.

Market cap $2.1B
P/E (TTM) 54.6
52-week range $26.87 – $51.40
Avg volume 156.9K

as of Jul 17, 2026

OMCL insider trades

SEC Form 4 · last 90 days · newest reported trade 17 Aug 2026
Open-market buys 0
Open-market sells 2
Net sold $584K
Non-trade filings 4
Date Insider Type Shares Value
17 Aug 2026 Njoku Nnamdi President & COO Sell 3,083 $114K
15 Jul 2026 LIPPS RANDALL A CHAIRMAN, CEO Sell 10,000 $470K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
15 Aug 2026 LIPPS RANDALL A CHAIRMAN, CEO Tax withheld 12,350 $461K
15 Aug 2026 Manley Corey J EVP&CHIEF LEGAL/ADMIN OFFICER Tax withheld 4,025 $150K
15 Aug 2026 NUTT BRIAN H. VP, Chief Accounting Officer Tax withheld 937 $35K
15 Aug 2026 Njoku Nnamdi President & COO Tax withheld 3,670 $137K

OMCL reported financials

SEC EDGAR XBRL SEC EDGAR

OMCL reported revenue of $1.2B for the fiscal year ended 31 Dec 2025. Net income over the same period was $2.1M.

Figure Reported Period
Revenue $1.2B 31 Dec 2025 fiscal year
Net income $2.1M 31 Dec 2025 fiscal year
Diluted EPS $0.04 31 Dec 2025 fiscal year
Total assets $2.0B 30 Jun 2026 at period end
Total equity $1.3B 30 Jun 2026 at period end

OMCL earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.52 —
31 Mar 2026 Q1 2026 $0.25 —
31 Dec 2025 FY 2025 $0.04 —
30 Sep 2025 Q3 2025 $0.12 —
30 Jun 2025 Q2 2025 $0.12 —
31 Mar 2025 Q1 2025 −$0.15 —
31 Dec 2024 FY 2024 $0.27 —
30 Sep 2024 Q3 2024 $0.19 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

OMCL institutional holders

SEC Form 13F SEC EDGAR

10 of the 45 institutional funds we track reported a OMCL position for the quarter ended 30 Jun 2026 — a combined $163.5M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management Held (±25%) −24.2% shares 1,734,375 $72.0M
Two Sigma Investments Held (±25%) −24.4% shares 794,781 $33.0M
Renaissance Technologies Held (±25%) +23.4% shares 596,243 $24.8M
D. E. Shaw & Co. Trimmed −46.2% shares 287,461 $11.9M
Citadel Advisors New position 205,406 $8.5M
Point72 Asset Management Held (±25%) −23.0% shares 143,206 $5.9M
Man Group Added +178.2% shares 76,339 $3.2M
Bridgewater Associates New position 57,714 $2.4M
AQR Capital Management Held (±25%) +14.8% shares 36,561 $1.5M
Balyasny Asset Management Held (±25%) −19.6% shares 5,175 $215K

OMCL fails-to-deliver

SEC CNS data SEC

On 11 Sep 2026, 1,666 shares of OMCL failed to deliver (about $54K).

Settlement date Shares failed Notional % of shares out
11 Sep 2026 1,666 $54K 0.004%
04 Sep 2026 1,615 $56K 0.004%
31 Aug 2026 4,268 $141K 0.009%
28 Aug 2026 2,475 $83K 0.005%
27 Aug 2026 9,527 $319K 0.021%

Congressional trades in OMCL

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in OMCL is a sale by Sara Jacobs (house, CA), dated 09 Apr 2021.

Date Member Type Amount
09 Apr 2021 filed 28 May 2021 Sara Jacobs house · Democrat–CA Sale $50K–$100K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings